President Trump’s torrent of executive actions has spurred a flood of legal challenges seeking to thwart the president’s ...
The man who hopes to be President Donald Trump’s health secretary repeatedly asked to see “data” or “science” showing ...
Germany’s parliament is expected to vote Friday on an opposition bill calling for tougher rules on migration that could ...
Securing an end to the fighting in Ukraine must take place with Kyiv’s full involvement and come with more defense spending ...
Israeli strikes hit an unofficial border crossing in eastern Lebanon early Friday morning, killing two people and wounding 10 ...
Myanmar’s military government on Friday announced another six-month extension of its mandate to rule in preparation for ...
For a foreign correspondent in Mali, the assignment seemed like a dream: as Islamic extremists upended the region, Olivier ...
President Donald Trump’s abrupt freeze of U.S. foreign aid is sending shockwaves through Eastern Europe, leaving ...
When the mother of one of the Thai hostages held in the Gaza Strip for over a year caught sight of her son on a Facebook ...
South Carolina is preparing to execute the third inmate to be put to death since September as the state goes through a ...
After spending a freezing night out in the open, hundreds of striking students on Friday resumed their 2-day anti-graft protest march from the capital, Belgrade, to the ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.